W. Godefroy

Alpha-interferon therapy and cutaneous vascular lesions.

B. Dréno, P. Litoux, E. Billaud, 1989, Annals of internal medicine.

Low‐dose recombinant interferon‐α in the treatment of cutaneous T‐cell lympbomas

B. Dréno, B. Bureau, W. Godefroy, 1989 .

Induction of myelo‐monocytic My7 antigen (CD13) expression by interferon‐α in basal cells of cutaneous T‐cell lymphomas

B. Dréno, P. Litoux, B. Bureau, 1992, The British journal of dermatology.

The treatment of 45 patients with cutaneous T‐cell lymphoma with low doses of interferon‐α2a and etretinate

J. Ortonne, L. Thill, B. Dréno, 1991, The British journal of dermatology.

REGRESSION OF EXCESSIVE BONE REMODELLING BY INTERFERON ALPHA‐2‐A IN A PATIENT WITH HAIRY CELL LEUKEMIA: To the Editor:

J. Rossi, R. Bataille, C. Marcelli, 1988, European journal of haematology.

Low-dose recombinant interferon-alpha in the treatment of cutaneous T-cell lymphomas.

B. Dréno, P. Litoux, B. Bureau, 1989, The British journal of dermatology.